Investor insights
Sectors invested in
Research and Development1
Medicines1
Patient Care1
Life Science1
Health Care1
Biotechnology1
Inflammatory Disease1
Chronic Disease1
Funding rounds participated in
$50M sweet spot round size
Most of their 1 investments are in rounds between $50M and $50M
Investor type
Venture Capital
Basic info
Industry
venture capital and private equity principals
Sectors
Financial Services
Venture Capital and Life Sciences
Life Science
Venture Capital
Date founded
2021
Investments made
E
Evommune raised $50M on April 26, 2023
Investors: Arix Bioscience plc, Amplitude Ventures, Andera Partners, EQT Life Sciences and SymBiosis